Race and Socioeconomic Status Influence Outcomes of Unrelated Donor Hematopoietic Cell Transplantation

Biology of Blood and Marrow Transplantation

Volumn 15, Issue 12, 2009, Pages 1543-1554

  Baker, K Scott ^a   Davies, Stella M ^b   Majhail, Navneet S ^c,d   Hassebroek, Anna ^d   Klein, John P ^e   Ballen, Karen K ^f   Bigelow, Carolyn L ^g   Frangoul, Haydar A ^h   Hardy, Cheryl L ^g   Bredeson, Christopher ⁱ   Dehn, Jason ^j   Friedman, Debra ^h   Hahn, Theresa ^k   Hale, Gregory ^l   Lazarus, Hillard M ^m   LeMaistre, C F ⁿ   Loberiza, Fausto ^o   Maharaj, Dipnarine ^p   McCarthy, Philip ^k   Setterholm, Michelle ^j   Spellman, Stephen ^j   Trigg, Michael ^q   Maziarz, Richard T ^r   Switzer, Galen ^s   Lee, Stephanie J ^a   Rizzo, J Douglas ^e   more..

^a Fred Hutchinson Cancer Research Center   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d CENTER FOR INTERNATIONAL BLOOD AND MARROW TRANSPLANT RESEARCH   (United States)

^e CENTER FOR INTERNATIONAL BLOOD AND MARROW TRANSPLANT RESEARCH   (United States)

^f MASSACHUSETTS GENERAL HOSPITAL   (United States)

^g UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^h VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

ⁱ MEDICAL COLLEGE OF WISCONSIN   (United States)

^j NATIONAL MARROW DONOR PROGRAM   (United States)

^k ROSWELL PARK CANCER INSTITUTE   (United States)

^l JOHNS HOPKINS ALL CHILDREN S HOSPITAL   (United States)

^m UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

ⁿ TEXAS TRANSPLANT INSTITUTE   (United States)

^o UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^p South Florida Bone Marrow Stem Cell Transplant Institute   (United States)

^q MERCK RESEARCH LABORATORIES   (United States)

^r OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^s UNIVERSITY OF PITTSBURGH   (United States)

more..

Author keywords

Allogeneic hematopoietic cell transplantation; Race; Socioeconomic status; Survival; Unrelated donor

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; METHOTREXATE; TACROLIMUS;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AFRICAN AMERICAN; ARTICLE; ASIAN; BLOOD DONOR; CAUCASIAN; CHILD; CHRONIC MYELOID LEUKEMIA; COMORBIDITY; CONTROLLED STUDY; DONOR SELECTION; DRUG METABOLISM; FEMALE; GENETIC POLYMORPHISM; GRAFT RECIPIENT; GRAFT VERSUS HOST REACTION; HEALTH BEHAVIOR; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISPANIC; HLA MATCHING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCOME; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYELOABLATIVE CONDITIONING; MYELODYSPLASTIC SYNDROME; OUTCOME ASSESSMENT; PACIFIC ISLANDER; RACE DIFFERENCE; SOCIAL STATUS; SOCIOECONOMICS; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; CONTINENTAL POPULATION GROUPS; DISEASE-FREE SURVIVAL; FEMALE; HEALTH STATUS DISPARITIES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RECURRENCE; RETROSPECTIVE STUDIES; SOCIAL CLASS; TISSUE DONORS; TRANSPLANTATION CONDITIONING; TREATMENT OUTCOME; YOUNG ADULT;

EID: 70350774049     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2009.07.023     Document Type: Article

References (52)

1. Asbell S.O., and Vijayakumar S. Racial differences in prostate-specific antigen levels in patients with local-regional prostate cancer. Prostate 31 (1997) 42-46
2. Iselin C.E., Box J.W., Vollmer R.T., Layfield L.J., Robertson J.E., and Paulson D.F. Surgical control of clinically localized prostate carcinoma is equivalent in African-American and white males. Cancer 83 (1998) 2353-2360
3. Kim J.A., Kuban D.A., el-Mahdi A.M., and Schellhammer P.F. Carcinoma of the prostate: race as a prognostic indicator in definitive radiation therapy. Radiology 194 (1995) 545-549
4. Mayberry R.M., Coates R.J., Hill H.A., et al. Determinants of black/white differences in colon cancer survival. J Natl Cancer Inst 87 (1995) 1686-1693
5. Arbes S.J., and Slade G.D. Racial differences in stage at diagnosis of screenable oral cancers in North Carolina. J Public Health Dent 56 (1996) 352-354
6. Rubnitz J.E., Lensing S., Razzouk B.I., Pounds S., Pui C.H., and Ribeiro R.C. Effect of race on outcome of white and black children with acute myeloid leukemia: the St. Jude experience. Pediatr Blood Cancer 48 (2007) 10-15
7. Metzger M.L., Castellino S.M., Hudson M.M., et al. Effect of race on the outcome of pediatric patients with Hodgkin's lymphoma. J Clin Oncol 26 (2008) 1282-1288
8. Bain R.P., Greenberg R.S., and Whitaker J.P. Racial differences in survival of women with breast cancer. J Chronic Dis 39 (1986) 631-642
9. Moul J.W., Douglas T.H., McCarthy W.F., and McLeod D.G. Black race is an adverse prognostic factor for prostate cancer recurrence following radical prostatectomy in an equal access health care setting. J Urol 155 (1996) 1667-1673
10. Lannin D.R., Mathews H.F., Mitchell J., Swanson M.S., Swanson F.H., and Edwards M.S. Influence of socioeconomic and cultural factors on racial differences in late-stage presentation of breast cancer. JAMA 279 (1998) 1801-1807
11. Franzini L., Williams A.F., Franklin J., Singletary S.E., and Theriault R.L. Effects of race and socioeconomic status on survival of 1,332 black, Hispanic, and white women with breast cancer. Ann Surg Oncol 4 (1997) 111-118
12. Serna D.S., Lee S.J., Zhang M.J., et al. Trends in survival rates after allogeneic hematopoietic stem-cell transplantation for acute and chronic leukemia by ethnicity in the United States and Canada. J Clin Oncol 21 (2003) 3754-3760
13. Baker K.S., Loberiza Jr. F.R., Yu H., et al. Outcome of ethnic minorities with acute or chronic leukemia treated with hematopoietic stem-cell transplantation in the United States. J Clin Oncol 23 (2005) 7032-7042
14. Mielcarek M., Gooley T., Martin P.J., et al. Effects of race on survival after stem cell transplantation. Biol Blood Marrow Transplant 11 (2005) 231-239
15. Cavet J., Middleton P.G., Segall M., Noreen H., Davies S.M., and Dickinson A.M. Recipient tumor necrosis factor-alpha and interleukin-10 gene polymorphisms associate with early mortality and acute graft-versus-host disease severity in HLA-matched sibling bone marrow transplants. Blood 94 (1999) 3941-3946
16. Dickinson A.M., Harrold J.L., and Cullup H. Haematopoietic stem cell transplantation: can our genes predict clinical outcome?. Expert Rev Mol Med 9 (2007) 1-19
17. Oh H., Loberiza Jr. F.R., Zhang M.J., et al. Comparison of graft-versus-host-disease and survival after HLA-identical sibling bone marrow transplantation in ethnic populations. Blood 105 (2005) 1408-1416
18. Sinnott R. Virtues of the Haversine. Sky Telescope (1984) 159
19. Zip-Codes.com. Zip Code Database-Deluxe Database specifications.
20. Farag S.S., Eapen M., Hurley C., et al. KIR Study Group, Center for International Blood and Marrow Transplantation Research. The effect of KIR ligand incompatibility on the outcome of unrelated donor transplants: a report from the Center for International Blood and Marrow Transplant Research, the European Blood and Marrow Transplant Registry and the Dutch Registry. Biol Blood Marrow Transplant 12 (2006) 876-884
21. Clark T.G., Altman D.G., and De Stavola B.L. Quantification of the completeness of follow-up. Lancet 359 (2002) 1309-1310
22. Przepiorka D., Weisdorf D., Martin P., et al. 1994 Consensus conference on acute GVHD grading. Bone Marrow Transplant 15 (1995) 825-828
23. Sullivan K.M., Agura E., Anasetti C., et al. Chronic graft-versus-host disease and other late complications of bone marrow transplantation. Semin Hematol 28 (1991) 250-259
24. Ringden O., Pavletic S.Z., Anasetti C., et al. The graft-versus-leukemia effect using matched unrelated donors is not superior to HLA-identical siblings for hematopoietic stem cell transplantation. Blood 113 (2009) 3110-3118
25. Weisdorf D., Spellman S., Haagenson M., et al. Classification of HLA-matching for retrospective analysis of unrelated donor transplantation: revised definitions to predict survival. Biol Blood Marrow Transplant 14 (2008) 748-758
26. Szydlo R., Goldman J.M., Klein J.P., et al. Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings. J Clin Oncol 15 (1997) 1767-1777
27. Pasquini M., and Wang Z. CIBMTR summary slides-2007 (Part 2). CIBMTR Newslett 14 (2008) 6-13
28. Klein JaW J.T. Discretizing a continuous covariate in survival studies. Handbook of Statistics. Advances in Survival Analysis, Vol. 25 (2004), Elsevier Science, New York
29. Andersen CA. Score tests of homogeneity for survival data. Lifetime Data Anal. 1:145-156.
30. Lohmueller K.E., Indap A.R., Schmidt S., et al. Proportionally more deleterious genetic variation in European than in African populations. Nature 451 (2008) 994-997
31. Kim D.H., Park J.Y., Sohn S.K., Lee N.Y., Suh J.S., and Lee K.B. The association between multidrug resistance-1 gene polymorphisms and outcomes of allogeneic HLA-identical stem cell transplantation. Haematologica 91 (2006) 848-851
32. Chesney R.W., and Wyatt R.J. Racial disparities in renal transplantation in children. Pediatrics 112 (2003) 409-411
33. Nair S., Eustace J., and Thuluvath P.J. Effect of race on outcome of orthotopic liver transplantation: a cohort study. Lancet 359 (2002) 287-293
34. McDonald G.B., Slattery J.T., Bouvier M.E., et al. Cyclophosphamide metabolism, liver toxicity, and mortality following hematopoietic stem cell transplantation. Blood 101 (2003) 2043-2048
35. Robien K., Schubert M.M., Bruemmer B., Lloid M.E., Potter J.D., and Ulrich C.M. Predictors of oral mucositis in patients receiving hematopoietic cell transplants for chronic myelogenous leukemia. J Clin Oncol 22 (2004) 1268-1275
36. Srivastava A., Poonkuzhali B., Shaji R.V., et al. Glutathione S-transferase M1 polymorphism: a risk factor for hepatic venoocclusive disease in bone marrow transplantation. Blood 104 (2004) 1574-1577
37. Robien K., Bigler J., Yasui Y., et al. Methylenetetrahydrofolate reductase and thymidylate synthase genotypes and risk of acute graft-versus-host disease following hematopoietic cell transplantation for chronic myelogenous leukemia. Biol Blood Marrow Transplant 12 (2006) 973-980
38. McCune J.S., Batchelder A., Deeg H.J., et al. Cyclophosphamide following targeted oral busulfan as conditioning for hematopoietic cell transplantation: pharmacokinetics, liver toxicity, and mortality. Biol Blood Marrow Transplant 13 (2007) 853-862
39. Suarez-Kurtz G., and Pena S.D. Pharmacogenomics in the Americas: the impact of genetic admixture. Curr Drug Targets 7 (2006) 1649-1658
40. Spielman R.S., Bastone L.A., Burdick J.T., Morley M., Ewens W.J., and Cheung V.G. Common genetic variants account for differences in gene expression among ethnic groups. Nat Genet 39 (2007) 226-231
41. Zhang W., Duan S., Kistner E.O., et al. Evaluation of genetic variation contributing to differences in gene expression between populations. Am J Hum Genet 82 (2008) 631-640
42. Popescu I., Vaughan-Sarrazin M.S., and Rosenthal G.E. Differences in mortality and use of revascularization in black and white patients with acute MI admitted to hospitals with and without revascularization services. JAMA 297 (2007) 2489-2495
43. Stafford R.S., Saglam D., and Blumenthal D. National patterns of angiotensin-converting enzyme inhibitor use in congestive heart failure. Arch Intern Med 157 (1997) 2460-2464
44. Ayanian J.Z., Weissman J.S., Chasan-Taber S., and Epstein A.M. Quality of care by race and gender for congestive heart failure and pneumonia. Med Care 37 (1999) 1260-1269
45. Kahn K.L., Pearson M.L., Harrison E.R., et al. Health care for black and poor hospitalized Medicare patients. JAMA 271 (1994) 1169-1174
46. Rathore S.S., Foody J.M., Wang Y., et al. Race, quality of care, and outcomes of elderly patients hospitalized with heart failure. JAMA 289 (2003) 2517-2524
47. Winkleby M.A., Kraemer H.C., Ahn D.K., and Varady A.N. Ethnic and socioeconomic differences in cardiovascular disease risk factors: findings for women from the Third National Health and Nutrition Examination Survey, 1988-1994. JAMA 280 (1998) 356-362
48. Zell J.A., Cinar P., Mobasher M., Ziogas A., Meyskens Jr. F.L., and Anton-Culver H. Survival for patients with invasive cutaneous melanoma among ethnic groups: the effects of socioeconomic status and treatment. J Clin Oncol 26 (2008) 66-75
49. Zell J.A., Rhee J.M., Ziogas A., Lipkin S.M., and Anton-Culver H. Race, socioeconomic status, treatment, and survival time among pancreatic cancer cases in California. Cancer Epidemiol Biomarkers Prev 16 (2007) 546-552
50. Mackillop W.J., Zhang-Salomons J., Groome P.A., Paszat L., and Holowaty E. Socioeconomic status and cancer survival in Ontario. J Clin Oncol 15 (1997) 1680-1689
51. Yoo H.Y., and Thuluvath P.J. Outcome of liver transplantation in adult recipients: influence of neighborhood income, education, and insurance. Liver Transpl 10 (2004) 235-243
52. SEER Cancer Statistics Review 1975-2006. Available at:. http://www.seer.cancer.gov/csr/1975_2006/browse_csr.php?section=13&p age=sect_13_table.07.html Accessed July 21, 2009